Ashkenazi Jewish Breast Cancer Test
The Ashkenazi Jewish Breast Cancer Test detects the presence of the following three mutations associated with breast cancer risk for individuals of Ashkenazi Jewish descent:
1. NM_007300.3:c.68_69del (p.Glu23Valfs*17)
    Legacy: BRCA1 185delAG or 187delAG
2. NM_007300.3:c.5329dup (p.Gln1777Profs*74)
    Legacy: BRCA1 5382insC or 5385insC or 5266dupC
3.NM_000059.3:c.5946del (p.Ser1982Argfs*22)
    Legacy: BRCA2 6174delT
CPT Code | 81162 |
Gene | Reason | Reference |
---|---|---|
BRCA1 | Heterozygous pathogenic variants in the BRCA1 gene are the most common cause of hereditary breast and ovarian cancer syndrome (HBOC). | PubMed: 9497246, 12677558, 17416853, 20301425, 22846731, 26424758, 35683509 |
BRCA2 | Autosomal dominant mutations in the BRCA2 gene are implicated in the hereditary breast and ovarian cancer syndrome (HBOC). Additionally, biallelic mutations in BRCA2 gene are associated with autosomal recessive Fanconi anemia Types B and D1 . | PubMed: 12065746, 12677558, 9497246, 17416853, 18042939, 20301425, 22846731; PMC: 2267287, 26424758, 35683509 |